SIGN UP
LOG IN
This UnitedHealth Group Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Benzinga·06/11/2025 14:52:35
Listen to the news
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Jefferies analyst Julien Dumoulin-Smith downgraded Sunrun Inc. (NASDAQ:RUN) from Hold to Underperform and lowered the price target from $6 to $5. Sunrun shares closed at $8.86 on Tuesday. See how other analysts view this stock.
- Baird analyst Michael Ha downgraded the rating for UnitedHealth Group Incorporated (NYSE:UNH) from Outperform to Neutral and lowered the price target from $356 to $312. UnitedHealth shares closed at $303.79 on Tuesday. See how other analysts view this stock.
- Goldman Sachs analyst Kash Rangan downgraded GitLab Inc. (NASDAQ:GTLB) from Buy to Neutral and cut the price target from $63 to $50. GitLab shares closed at $48.51 on Tuesday. See how other analysts view this stock.
- Morgan Stanley analyst Keith Weiss downgraded BILL Holdings, Inc. (NYSE:BILL) from Overweight to Equal-Weight and lowered the price target from $60 to $55. BILL Holdings shares closed at $45.37 on Tuesday. See how other analysts view this stock.
- D. Boral Capital analyst Jason Kolbert downgraded the rating for Artelo Biosciences, Inc. (NASDAQ:ARTL) from Buy to Hold. Artelo Biosciences shares closed at $1.13 on Tuesday. See how other analysts view this stock.
Considering buying UNH stock? Here’s what analysts think:
Read This Next:
Photo via Shutterstock
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.